UBS Group »

Carmell Therapeutics Corp - US shares owned by UBS Group

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCXW) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $4 116 0.04
2024-09-30 $493 9.0k 0.06
2024-06-30 $8 131 0.07
2023-09-30 $569 2.7k 0.21